Suchergebnisse - "Singh, Jagdeep K"

PubPharm (15)

1

Corrigendum to : Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study

enthalten in: The British journal of surgery | 2022

von Fatayer, H. | O'Connell, R. | Bannon, F. | +18

ErratumFor: Br J Surg. 2022 Aug 16;109(9):800-803. - PMID 35543289

2

Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer : UK NeST study

enthalten in: The British journal of surgery | 2022

von Fatayer, H. | O'Connell, R. | Bannon, F. | +118

ErratumIn: Br J Surg. 2022 Dec 13;110(1):124. - PMID 36075875

3

Multicentre prospective observational study evaluating recommendations for mastectomy by multidisciplinary teams

enthalten in: The British journal of surgery | 2020

von Mastectomy Decisions Audit (MasDA) Collaborative, o. | Singh, J. | McEvoy, K. | +98

4

Targeting IL-8 signalling to inhibit breast cancer stem cell activity

enthalten in: Expert opinion on therapeutic targets | 2013

von Singh, J. | Simões, B. | Clarke, R. | +1

5

Targeting IL-8 signalling to inhibit breast cancer stem cell activity

enthalten in: Expert opinion on therapeutic targets | 2013

von Singh, J. | Simões, B. | Clarke, R. | +1

6

Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells

enthalten in: Breast cancer research | 2013

von Singh, J. | Simões, B. | Howell, S. | +2

7

Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells

enthalten in: Breast cancer research | 2013

von Singh, J. | Simões, B. | Howell, S. | +2

8

Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2013

von Singh, J. | Farnie, G. | Bundred, N. | +5

CommentIn: Clin Cancer Res. 2013 Feb 1;19(3):511-3. - PMID 23251003

9

Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms

enthalten in: Clinical cancer research | 2013

von Singh, J. | Farnie, G. | Bundred, N. | +5

10

Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells

enthalten in: Breast cancer research : BCR | 2013

von Singh, J. | Simões, B. | Howell, S. | +2